Top Suppliers:I want be here

149709-62-6

149709-62-6 structure
149709-62-6 structure
  • Name: AHU 377
  • Chemical Name: Sacubitril
  • CAS Number: 149709-62-6
  • Molecular Formula: C24H29NO5
  • Molecular Weight: 411.491
  • Catalog: Biochemical Inhibitor Endocrinology & Hormones RAAS inhibitor
  • Create Date: 2018-03-29 08:00:00
  • Modify Date: 2026-06-29 17:53:55
  • Sacubitril (AHU-377) is a potent NEP inhibitor with an IC50 of 5 nM. Sacubitril (AHU-377) is a component of the heart failure medicine LCZ696.

Name Sacubitril
Synonyms AHU-377
(2R,4S)-4-[(3-Cboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic Acid Ethyl Ester
ENTRESTO
Sacubtril(LCZ696)
D4-Sacubitril Calcium
SACUBRITIL
LCZ-696-S4R
4-{[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid
AHU-37
Sacubitril Related Compound 1
Sacubitril Control
AHU377
(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-cboxypropanamido)-2-methylpentanoic acid (Sacubitril , AHU-377)
Sacubitril, 10 mM in DMSO
Entresto( sacubitril+ valstan)
Sacubitril API
AHU-377 (Sacubitril calcium)
LCZ696(valstan + sacubitril) impurity 4
[1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-cboxy-1-oxopropyl)amino]-α-methyl-, α-ethyl ester, (αR,γS)
AHU-377(Sacubitril)
4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid
4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid
AHU377; AHU 377; SACUBITRIL
4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxo
Sacubitril : (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-cboxypropionyl) amino]-2-methylpentanoic acid ethyl ester
valstan/sacubitril Impurity 1
SacubitrilQ: What is Sacubitril Q: What is the CAS Number of Sacubitril Q: What is the storage condition of Sacubitril Q: What e the applications of Sacubitril
Sacubitril(AHU-377)
AHU-377 //BP
Sacubitril - Bio-X
UNII-17ERJ0MKGI
(2R,4S)-5-(Biphenyl-4-yl)-4-[(3-cboxypropionyl)amino]-2-methylpentanoic acid ethyl ester
4-[[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentyl]amino]-4-oxobutanoic Acid
4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid
Sacubitril Standd
4-《(2S,4R)-I-([I,I'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amin
AHU-377;AHU 377 ;AHU377
LCZ-696 Impurity 3
(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-cboxypropanamido)-2-methylpentanoic acid
AHU-77
4-(((2S,4R)-1-([1,1'-Biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic a
4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid
LCZ697
Description Sacubitril (AHU-377) is a potent NEP inhibitor with an IC50 of 5 nM. Sacubitril (AHU-377) is a component of the heart failure medicine LCZ696.
Related Catalog
Target

IC50: 5 nM (NEP)[1]

In Vitro Sacubitril (AHU-377) is a single molecule that is comprised of molecular moieties of valsartan, an ARB, and Sacubitril (AHU-377), a neprilysin inhibitor (1:1 ratio). Sacubitril (AHU-377) is converted by enzymatic cleavage of the ethyl ester into the active neprilysin inhibiting metabolite LBQ657[2]. The inactive NEPi precursor, Sacubitril (AHU-377), does not inhibit collagen accumulation in fibroblasts nor cardiac myocyte hypertrophy. In cardiac fibroblasts, the active NEPi LBQ657 had no discernible effects. In contrast, LBQ657 modestly inhibits cardiac myocyte hypertrophy[3].
In Vivo In humans, Sacubitril (AHU-377) (tmax 0.5-1.1 h) are absorbed quickly. Sacubitril (AHU-377) is converted rapidly into LBQ657 with its tmax being reached in 1.9-3.5 h. Mean t1/2 values for the biologically active LBQ657 is 9.9-11.1 h[2]. In vehicle-treated dogs, ANF increases urinary sodium excretion from 17.3±3.6 to 199.5±18.4 pequivkglmin. This effect is potentiated significantly in animals which receive Sacubitril (AHU-377). Urinary volume is also potentiated in animals which receive an iv administration of Sacubitril (AHU-377)[1].
References

[1]. Ksander GM, et al. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors. J Med Chem. 1995 May 12;38(10):1689-700.

[2]. Voors AA, et al. The potential role of valsartan + AHU377 ( LCZ696 ) in the treatment of heart failure. Expert Opin Investig Drugs. 2013 Aug;22(8):1041-7.

[3]. von Lueder TG, et al. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. Circ Heart Fail. 2015 Jan;8(1):71-8.

Density 1.2±0.1 g/cm3
Boiling Point 656.9±55.0 °C at 760 mmHg
Molecular Formula C24H29NO5
Molecular Weight 411.491
Flash Point 351.1±31.5 °C
Exact Mass 411.204559
PSA 96.19000
LogP 3.96
Vapour Pressure 0.0±2.1 mmHg at 25°C
Index of Refraction 1.549
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.